Examines the efficacy and safety of nucleotide analog reverse-transcriptase inhibitor tenofovir disoproxil fumarate for the treatment of HIV infection and hepatitis B virus in the U.S. Reduction of the levels HIV RNA; Accounts on the factors attributing to mitochondrial toxicity; Risk factor for acquiring HIV infection.